1. AB0879 Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Paediatric Patients from Two To Less than Eighteen Years of Age with Juvenile Idiopathic Arthritis. (15th July 2016) Authors: Ruperto, N.; Brunner, H.I.; Hazra, A.; Wang, R.; Mebus, C.; Alvey, C.; Lamba, M.; Krishnaswami, S.; Conte, U.; Wang, M.; Tzaribachev, N.; Foeldvari, I.; Horneff, G.; Kingsbury, D.; Koskova, E.; Smolewska, E.; Vehe, R.K.; Zuber, Z.; Martini, A.; Lovell, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0528 Canakinumab in Systemic Juvenile Idiopathic Arthritis: Impact on the Rate and Clinical Presentation of Macrophage Activation Syndrome. (10th June 2014) Authors: Grom, A.A.; Brunner, H.I.; Ruperto, N.; Martini, A.; Lovell, D.; Pascual, V.; Lheritier, K.; Abrams, K.; Ilowite, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0180 Maintenance of Efficacy by Canakinumab Treatment in Systemic Juvenile Idiopathic Arthritis Patients. (10th June 2014) Authors: Wulffraat, N.M.; Ruperto, N.; Brunner, H.I.; Oliveira, S.; Uziel, Y.; Nistala, K.; Cimaz, R.; Ferrandiz, M.A.; Flato, B.; Gamir, M.L.; Koné-Paut, I.; Gaillez, C.; Lheritier, K.; Abrams, K.; Martini, A.; Lovell, D.J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0182 A Pharmacometric-Based Analysis Indicated NO Relationship between Occurrence of Safety Events and Canakinumab Exposure in Systemic Juvenile Idiopathic Arthritis Patients. (10th June 2014) Authors: Dumortier, T.; Ruperto, N.; Brunner, H.I.; Luttringer, O. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0215 Subcutaneous Abatacept in Patients with Polyarticular Juvenile Idiopathic Arthritis and Inadequate Response To Biologic or Non-Biologic Disease-Modifying Antirheumatic Drugs: Pharmacokinetics, Efficacy and Safety. (15th July 2016) Authors: Ruperto, N.; Lovell, D.J.; Tzaribachev, N.; Vega-Cornejo, G.; Louw, I.; Berman, A.; Calvo, I.; Cuttica, R.; Horneff, G.; Avila-Zapata, F.; Anton, J.; Viola, D.; Foeldvari, I.; Keltsev, V.; Kingsbury, D.; Li, X.; Nys, M.; Wong, R.; Banerjee, S.; Martini, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0215 Long-Term Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA): 5-Year Follow-up of An Open-Label Trial. (15th July 2016) Authors: Ruperto, N.; Brunner, H.I.; Quartier, P.; Constantin, T.; Alexeeva, E.; Schneider, R.; Kone-Paut, I.; Schikler, K.; Marzan, K.; Wulffraat, N.; Padeh, S.; Chasnyk, V.; Wouters, C.; Kuemmerle-Deschner, J.B.; Kallinich, T.; Lauwerys, B.; Haddad, E.; Nasonov, E.; Trachana, M.; Vougiouka, O. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0216 Safety and Effectiveness of Adalimumabmethotrexate for The Treatment of Polyarticular Juvenile Idiopathic Arthritis (PJIA): Strive Registry. (15th July 2016) Authors: Ruperto, N.; Lovell, D.J.; Wallace, C.; Toth, M.; Foeldvari, I.; Bohnsack, J.; Milojevic, D.; Rabinovich, E.; Kingsbury, D.; Marzan, K.; Quartier, P.; Minden, K.; Chalom, E.; Horneff, G.; Kuester, R.M.; Dare, J.; Heinrich, M.; Kupper, H.; Kalabic, J.; Martini, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0547 Real-world effectiveness of early aggressive treatment with biological disease-modifying antirheumatic drugs for the treatment of newly diagnosed polyarticular form of juvenile idiopathic arthritis. (12th June 2018) Authors: Huang, B.; Morgan, E.M.; Chen, C.; Guo, J.; Lovell, D.J.; Brunner, H.I. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0579 Treating To Target with Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis: Results from The Long-Term Extension The Phase III Pivotal Trial. (15th July 2016) Authors: Ruperto, N.; Brunner, H.I.; Quartier, P.; Constantin, T.; Alexeeva, E.; Kone-Paut, I.; Marzan, K.; Wulffraat, N.; Schneider, R.; Padeh, S.; Chasnyk, V.; Wouters, C.; Kuemmerle-Deschner, J.B.; Kallinich, T.; Lauwerys, B.; Haddad, E.; Nasonov, E.; Trachana, M.; Vougiouka, O.; Leon, K. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗